+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 181 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5983119
Free Webex Call
10% Free customization
Description Jump to:

Branded is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Anti-Viral Drugs Market, valued at USD 77.10 Billion in 2024, is projected to experience a CAGR of 3.89% to reach USD 96.94 Billion by 2030. Antiviral drugs are pharmaceutical agents developed to inhibit viral replication and proliferation within a host, thereby treating or preventing viral infections such as HIV, hepatitis, and influenza. The market's growth is primarily driven by the escalating global incidence of viral diseases, substantial investments in pharmaceutical research and development, and proactive public health campaigns for infection control.

Key Market Drivers

The increasing global prevalence of viral infections stands as a significant driver for the antiviral drugs market, creating an enduring demand for effective therapeutic solutions. The continuous emergence of new viral strains and the persistent burden of established pathogens pose substantial public health challenges, from seasonal outbreaks to widespread epidemics. For example, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in its 2023 Global AIDS Update, an estimated 1.3 million people worldwide became newly infected with HIV in 2022. This ongoing incidence necessitates the development of advanced antiviral treatments to manage and prevent disease progression, thereby directly influencing market demand for these crucial pharmaceutical products.

Key Market Challenges

The rapid evolution of viral resistance to existing therapeutic agents presents a significant obstacle to the sustained growth of the global anti-viral drugs market. As viruses mutate and develop resistance, the efficacy of current treatments diminishes, necessitating the continuous development of novel compounds. This ongoing requirement for new pharmaceutical agents directly impedes market expansion by escalating development costs and increasing regulatory complexities.

Key Market Trends

The growing adoption of AI-driven drug discovery for antivirals represents a significant shift in pharmaceutical research, aiming to accelerate the identification and development of novel compounds. This trend leverages advanced computational techniques to analyze vast biological datasets, predict molecular properties, and optimize drug designs, thereby streamlining the notoriously lengthy and expensive drug development process. According to a survey from cloud vendor Rackspace Technology and Dell/VMware conducted in October 2023, 67% of pharmaceutical companies planned to increase their IT investments, including AI, over the subsequent 12 months, highlighting this strategic pivot.

Key Market Players Profiled:

  • F. Hoffmann-La Roche Ltd
  • GSK plc.
  • AbbVie, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Aurobindo Pharma
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.

Report Scope:

In this report, the Global Anti-Viral Drugs Market has been segmented into the following categories:

By Type:

  • Branded
  • Generics

By Drug Class:

  • DNA Polymerase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • Neuraminidase Inhibitors
  • Others

By Application:

  • HIV
  • Hepatitis
  • Herpes
  • Influenza
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-Viral Drugs Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Anti-Viral Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Branded, Generics)
5.2.2. By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others)
5.2.3. By Application (HIV, Hepatitis, Herpes, Influenza, Others)
5.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Anti-Viral Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Drug Class
6.2.3. By Application
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Anti-Viral Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Drug Class
6.3.1.2.3. By Application
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Anti-Viral Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Drug Class
6.3.2.2.3. By Application
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Anti-Viral Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Drug Class
6.3.3.2.3. By Application
6.3.3.2.4. By Distribution Channel
7. Europe Anti-Viral Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Drug Class
7.2.3. By Application
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Anti-Viral Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Drug Class
7.3.1.2.3. By Application
7.3.1.2.4. By Distribution Channel
7.3.2. France Anti-Viral Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Drug Class
7.3.2.2.3. By Application
7.3.2.2.4. By Distribution Channel
7.3.3. United Kingdom Anti-Viral Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Drug Class
7.3.3.2.3. By Application
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Anti-Viral Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Drug Class
7.3.4.2.3. By Application
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Anti-Viral Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Drug Class
7.3.5.2.3. By Application
7.3.5.2.4. By Distribution Channel
8. Asia-Pacific Anti-Viral Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Drug Class
8.2.3. By Application
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Anti-Viral Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Drug Class
8.3.1.2.3. By Application
8.3.1.2.4. By Distribution Channel
8.3.2. India Anti-Viral Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Drug Class
8.3.2.2.3. By Application
8.3.2.2.4. By Distribution Channel
8.3.3. Japan Anti-Viral Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Drug Class
8.3.3.2.3. By Application
8.3.3.2.4. By Distribution Channel
8.3.4. South Korea Anti-Viral Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Drug Class
8.3.4.2.3. By Application
8.3.4.2.4. By Distribution Channel
8.3.5. Australia Anti-Viral Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Drug Class
8.3.5.2.3. By Application
8.3.5.2.4. By Distribution Channel
9. Middle East & Africa Anti-Viral Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Drug Class
9.2.3. By Application
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Anti-Viral Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Drug Class
9.3.1.2.3. By Application
9.3.1.2.4. By Distribution Channel
9.3.2. UAE Anti-Viral Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Drug Class
9.3.2.2.3. By Application
9.3.2.2.4. By Distribution Channel
9.3.3. South Africa Anti-Viral Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Drug Class
9.3.3.2.3. By Application
9.3.3.2.4. By Distribution Channel
10. South America Anti-Viral Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Drug Class
10.2.3. By Application
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Anti-Viral Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Drug Class
10.3.1.2.3. By Application
10.3.1.2.4. By Distribution Channel
10.3.2. Colombia Anti-Viral Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Drug Class
10.3.2.2.3. By Application
10.3.2.2.4. By Distribution Channel
10.3.3. Argentina Anti-Viral Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Drug Class
10.3.3.2.3. By Application
10.3.3.2.4. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Anti-Viral Drugs Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. F. Hoffmann-La Roche Ltd
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. GSK plc.
15.3. AbbVie, Inc.
15.4. Merck & Co., Inc.
15.5. Johnson & Johnson Services, Inc.
15.6. Bristol-Myers Squibb Company
15.7. Aurobindo Pharma
15.8. Cipla Limited
15.9. Dr. Reddy’s Laboratories Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Anti-Viral Drugs market report include:
  • F. Hoffmann-La Roche Ltd
  • GSK plc.
  • AbbVie, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Aurobindo Pharma
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 77.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 96.94 Billion
Compound Annual Growth Rate3.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Anti-Viral Drug Market - Forecasts from 2025 to 2030 - Product Image

Anti-Viral Drug Market - Forecasts from 2025 to 2030

  • Report
  • 144 Pages
  • Global
From
Antivirals Market Report 2025 - Product Image

Antivirals Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 181 Pages
  • Global
From
Saudi Arabia Antiviral Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

Saudi Arabia Antiviral Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 82 Pages
  • Saudi Arabia
From
Pregnancy and Anti-Infective Agents - Product Image

Pregnancy and Anti-Infective Agents

  • Book
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.